Paliperidone Palmitate

Preferred Label : Paliperidone Palmitate;

MeSH definition : A benzisoxazole derivative and active metabolite of RISPERIDONE that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST and SEROTONIN 5-HT2 RECEPTOR ANTAGONIST. It is an ANTIPSYCHOTIC AGENT used in the treatment of SCHIZOPHRENIA.;

MeSH synonym : Palmitate, Paliperidone;

MeSH hyponym : R 76477; Invega Sustenna; Invega; paliperidone; 9-OH-risperidone; 9 OH risperidone; 3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one; 9-Hydroxy-risperidone; 9 Hydroxy risperidone; 9-Hydroxyrisperidone; 9 Hydroxyrisperidone; Sustenna, Invega; R-76477; R76477;

MeSH Related Number : 199739-10-1 (paliperidone palmitate); 838F01T721;

Wikipedia link : https://en.wikipedia.org/wiki/Paliperidone;

Is substance : O;

UNII : R8P8USM8FR;

Details

Origin ID

D000068882;

UMLS CUI

C2719626;

ATC code(s)
- paliperidone [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- 9-Hydroxyrisperidone [LOINC component]
- 9-Hydroxyrisperidone Measurement [NCIt concept]
- 9-hydroxyrisperidone (substance) [Inactive SNOMED CT concept]
- Paliperidone [NCIt concept]
- Paliperidone [LOINC component]
- Paliperidone [ICD-11 Extension code]
- Paliperidone (substance) [SNOMED CT concept]
- paliperidone [ATC Code]
Currated CISMeF NLP mapping
- Paliperidone Palmitate [Substance BNPC]
- Paliperidone palmitate [International Nonproprietary Name]
- Paliperidone palmitate [SMS substance]
Exact mapping(s) to DCI
- Paliperidone palmitate [International Nonproprietary Name]
Pharmacological action(s)
- Dopamine D2 Receptor Antagonists [MeSH Descriptor]
- antipsychotic agents [MeSH Descriptor]
- central nervous system depressants [MeSH Descriptor]
- psychotropic drugs [MeSH Descriptor]
- serotonin 5-HT2 receptor antagonists [MeSH Descriptor]
Record concept(s)
- Invega [MeSH concept]
- Invega Sustenna [MeSH concept]
- R 76477 [MeSH concept]
- paliperidone [MeSH concept]
- paliperidone palmitate [MeSH concept]
Related MeSH Supplementary Concept(s)
- isoperidone [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Paliperidone Palmitate [NCIt concept]
- Paliperidone palmitate [International Nonproprietary Name]
- Paliperidone palmitate (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients